Equitas Medical raises seed round from Medley, Sumisho and Mirai Souzou to back clinic succession
What's the deal? Equitas Medical, a Tokyo-based startup supporting the succession of regional medical clinics, has raised a seed round through a third-party share allotment. Investors include Medley, Sumisho Venture PartnersDealroom has a profile for this one. Try Dealroom →, and Mirai SouzouDealroom has a profile for this one. Try Dealroom → Investments. The round was announced in August 2026.
What's the endgame? Equitas Medical wants to build a repeatable support model for clinics facing succession and management challenges. Acting as a management services (MS) company rather than a medical provider, it bundles services such as succession scheme design, staff recruitment, digital transformation, marketing, and back-office operations.
Why now? Japan's community clinics are strained by ageing directors, a lack of successors, and slow digitisation. Finding a successor doctor alone is not enough — succession requires business planning, financing, staffing, and IT setup, which small clinics struggle to handle on their own.
What's the money for? Equitas Medical plans to advance its regional medical succession support package and roll out clinic DX. Each investor brings a specific strength: Medley in medical staffing and healthcare software, Sumisho Venture Partners in domestic and overseas healthcare businesses, and Mirai Souzou in university-derived innovation via Institute of Science Tokyo.
The company is a certified venture of Institute of Science Tokyo, giving it access to the university's clinical, research, and technical resources. Co-founders Takanori Kuki and Imura previously worked at a trading company; Kuki served as an entrepreneur in residence at Mirai Souzou before founding the company.
What could go wrong? The model depends on coordinating many parties — successor doctors, medical corporations, financial institutions, and staff — while respecting the independence of medical providers. Executing this consistently across regions and specialties is unproven.
The signal: The round reflects growing interest in the "management" layer of Japanese healthcare, where recruitment, digitisation, and back-office support increasingly determine whether clinics survive succession. Equitas Medical eventually aims to export its playbook to clinics and pharmacies across Asia.
Read more: PR TIMES
Image credit: Generated with Gemini
